Share on StockTwits

Cyprotex plc (LON:CRX)‘s stock had its “corporate” rating reaffirmed by stock analysts at N+1 Singer in a report issued on Tuesday.

Shares of Cyprotex plc (LON:CRX) opened at 6.50 on Tuesday. Cyprotex plc has a 52-week low of GBX 5.00 and a 52-week high of GBX 8.25. The stock has a 50-day moving average of GBX 6.53 and a 200-day moving average of GBX 6.94.

Cyprotex PLC (LON:CRX) is a holding company specializing in preclinical ADME Tox, both in vitro (laboratory experiments) and in silico (computer modelling).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.